Afghans get $540m to bolster pandemic fight

A woman receives free bread from the municipality outside a bakery Thursday during the holy month of Ramadan in locked down Kabul. (AFP)
Short Url
Updated 01 May 2020

Afghans get $540m to bolster pandemic fight

  • Global pledges as anger grows over Kabul’s response to virus

KABUL: Afghanistan has been offered $540 million in grants and interest-free loans by international finance institutions to help the war-ravaged country’s fight against the coronavirus pandemic.

The global pledges come amid growing public anger at the government’s handling of the outbreak and claims of widespread misappropriation of health funds.

Ministry of Finance spokesman Shamrooz Khan Masjidi told Arab News on Thursday that the EU has offered $119 million, the World Bank $100 million and the Asian Development Bank $40 million, while the International Monetary Fund (IMF) approved an interest-free loan of $220 million to bolster Afghanistan’s pandemic response.

“This is a good step. The money will help the fight against the coronavirus and strengthen the country’s economic stability,” he said.

Masjidi said that the government will focus on addressing the health emergency and supporting people whose livelihoods have been affected by the pandemic.

According to the IMF, Afghanistan faces mounting problems as a result of the COVID-19 outbreak, with the country’s economy expected to contract sharply this year, “threatening the livelihood of a significant segment of the population.”

The promised international assistance is about 250 times greater than Afghanistan’s annual health care budget of $2.1 million.


The government will focus on addressing the health emergency and supporting people whose livelihoods have been affected by the pandemic.

After six weeks in lockdown, residents in Kabul and Jalalabad have started to ignore coronavirus restrictions and criticize the government’s response, saying that the virus “might not kill them, but hunger will.”

Thousands protested in Jalalabad on Thursday, accusing officials of corruption and failing to help those affected by the pandemic.

In Kabul, during a press conference with national medical representatives, members of the Senate sent a complaint to the Attorney General’s Office criticizing Health Minister Ferozuddin Feroz and presidential adviser Waheed Omar, director general of the Office of Public and Strategic Affairs.

The two officials were accused of “serious shortcomings” in handling the coronavirus outbreak, mismanagement of food deliveries to people affected by lockdowns, and corruption in buying medical equipment.

Neither was available for comment.

Torek Farhadi, a former Afghan government and IMF adviser, said that corruption is a growing concern in aid expenditure.

“Afghanistan ranks 173 out of 180 countries on Transparency International’s corruption perception index, which means it is perceived as one of the most corrupt in the world,” he told Arab News.

India’s medical body accused of ‘fixing’ vaccine trial date

Updated 40 min 33 sec ago

India’s medical body accused of ‘fixing’ vaccine trial date

  • Experts say move is part of efforts to showcase progress in handling outbreak

NEW DELHI: A day after India’s apex medical body issued a clarification for setting Aug. 15 as the deadline to fast-track the trials of a vaccine for the coronavirus disease (COVID-19), doctors and health experts said on Sunday that the Indian Council of Medical Research (ICMR) was “fixing the date” for the use of the coveted drug.

“It is no coincidence that this vaccine fixing trial by the ICMR comes soon after the flabbergasting claim made by Baba Ramdev (a yoga guru) of discovering the Ayurvedic cure for COVID-19,” Harjit Singh Bhatti of New Delhi-based Progressive Medicos and Scientific Forum told Arab News.

He added that the fact the order was issued to launch the vaccine for public use by Aug. 15 implied that the results had already been given. 

“The so-called trial is only an attempt to put a veneer of validity on them,” he said.

This follows the ICMR’s directive on Tuesday asking select medical institutions to expedite the clinical trial approvals for Covaxin, a potential anti-virus candidate developed in collaboration with Bharat Biotech International, a leading vaccine and bio-therapeutics manufacturer based in Hyderabad.

“In light of the public health emergency ... and urgency to launch the vaccine, you are strictly advised to fast-track all approvals related to the initiation of the clinical trial ... no later than July 7. It is envisaged to launch the vaccine for public health use latest by Aug. 15 after completion of all clinical trials,” Dr. Balram Bhargava, ICMR director-general, wrote in the order.

The ICMR chief warned hospitals not to delay the trials, adding that “non-compliance” would be taken “very seriously.”

Faced with growing outrage over the message, the ICMR issued a statement on Saturday that claimed the six-week deadline was “to cut red tape.”

“The letter by the ICMR director-general to investigators of the clinical trial sites was meant to cut unnecessary red tape, without bypassing any necessary process, and speed up recruitment of participants,” the statement said.

Health experts, however, said it was a “disturbing” development.

“It is very disturbing that the ICMR would fix a date for releasing a vaccine even before the Phase-1 trial has started. Everybody knows India mismanaged the epidemic. You cannot save face with this kind of approach to the vaccine,” Dr T. Jacob John, a biologist at the Vellore-based Christian Medical College in Tamil Nadu, told Arab News.

The missive has prompted a huge outcry among medical and political circles.

“Any doctor or scientist who has been trained to practice medicine with a scientific temperament in the service of our people would be outraged by the criminal audacity of the government,” Bhatti said.

He added that if “science were to have its way,” the trials would have been done in phases to ensure the vaccine was safe. 

Dr. Amar Jesani, Mumbai-based independent researcher and editor of the Indian Journal of Medical Ethics, said the idea was “laughable” and that it violated the ICMR’s guidelines on ethical medical practices.

“It’s a pipe dream, and you cannot have a vaccine by commanding that the vaccine should work,” Jesani told Arab News.

Meanwhile, Soumya Swaminathan, chief scientist of the World Health Organization (WHO), warned that the vaccine should not come at “the cost of scientific and ethical standards.”

“The WHO recommends that Phase-3 trials, often considered the most important, should involve up to 20-30,000 people,” she said in an interview with Indian newspapers on Sunday.

As the chief medical body of the Indian government, the ICMR is tasked with formulating guidelines to deal with COVID-19 cases in the country. 

To this end, it sets the parameters for ethical standards in medical trials, while its head reports directly to the Prime Minister’s Office.

Following the developments on Saturday, questions are now being raised as to whether the ICMR was under political pressure.

Sitaram Yechury, leader of the Communist Party of India (Marxist), said scientists were being “forced” to show results so that Prime Minister Narendra Modi could announce them during his Independence Day speech on August 15. 

“Forcing the development of an indigenous vaccine as a cure for COVID-19 by bypassing all health and safety norms... is fraught with horrendous human costs,” he tweeted on Saturday.

Jesani reasons this is owing to a “direct relationship of power with the ICMR.”

“There is no doubt that the director-general of the ICMR was assigned to get going by August 15 so that there would be something positive for the PM to say in his address to the nation. He thinks that the vaccine is the best thing to talk about,” Jesani said, adding that it could also be a means for the ICMR to redeem itself.

“No doubt the ICMR has been under great pressure for the last three months and wants to redeem its credibility…[but] it is science that ultimately controls the outcome,” he said.

As of Sunday, India had over 700,000 active COVID-19 cases with more than 20,000 deaths reported.